Breaking News on Contract Research, Manufacturing & Clinical Trials

Hot Topics > Consolidation



The pharmaceutical industry seems besieged on all sides by declining R&D productivity, expiring patents and relentless downward pricing pressure. One effect of this onslaught has been an upsurge in the level of consolidation as industry players attempt to cut costs, expand research pipelines and lengthen geographic reach.

Dispatches from PCT

Not all good news: CROs must prepare for Private Equity exit, experts say

02-Dec-2013 - Private equity will be looking to exit the CRO industry and could pose a threat to recent strong growth, according to financial experts at PCT

Dispatches from PCT

Quintiles is the "arms, legs and brain" in Merck Serono's monogamous relationship

02-Dec-2013 - Trust, transparency and end-to-end participation are just some of the reasons Merck Serono says its exclusive strategic partnership with Quintiles is the “first of its kind.”

Venn acquires German CRO and says there's more to come

18-Nov-2013 - Venn Life Sciences has broadened its global footprint with the acquisition of a German CRO and says it is looking for more growth opportunities.

breaking news

PRA to buy CRI Lifetree

13-Nov-2013 - US CRO PRA International has announced plans to buy privately-owned early phase trial specialist CRI Lifetree.


'CROs on the move': inVentiv's new UK site; Novum in North Dakota

29-Oct-2013 - inVentiv Health has opened a new UK office in order to better target European customers, whilst Novum says its North Dakota facility will strengthen its offerings.

Aenova growing through consolidation with Haupt acquisition

28-Oct-2013 - CDMO Aenova has continued its strategy of consolidation with the acquisition of Haupt Pharma.

McKesson pushes for global reach with $8.3bn Celesio deal

28-Oct-2013 - McKesson Group has completed the acquisition of logistics firm Celesio as it eyes a global strategy, targeting the European and Latin America markets.

DrugDev acquires site payment specialist CFS Clinical

22-Oct-2013 - Sponsor network developer DrugDev on Monday announced it would acquire CFS Clinical, which specializes in managing the financing of clinical trials.  Financial terms were not disclosed.

DPT fielding calls from Ben Venue customers

17-Oct-2013 - US contractor DPT says it has received calls from customers of soon-to-close CMO Ben Venue Labs.

Catalent's Brazilian acquisition supports global softgel strategy

10-Oct-2013 - Catalent has continued its softgel expansion in emerging markets with the acquisition of Relthy Laboratórios in Brazil.

McKesson rumoured to be eyeing up Celesio; New CFO - People Gallery

10-Oct-2013 - McKesson Corporation who is said to be in talks to acquire German logistics company Celesio has appointed a new CFO and Executive Director - Welcome to Outsourcing-Pharma's People on the Move....

Cambridge Major Labs and AAIPharma Merge

08-Oct-2013 - AAIPharma says the merger with Cambridge Major Laboratories (CML) will bring clients the benefits of integrated Chemistry and Manufacturing Controls (CMC) services from two high-growth CMOs.

WCCT eyes niche market with early-stage opthalmic acquisition

26-Sep-2013 - WCCT Global has acquired OC Clinical Trials & Consulting to boost its early-stage ophthalmology services and fill a gap in the market, the firm says.

News in brief

PRA completes merger of RPS

25-Sep-2013 - The merger of PRA and RPS has been completed, creating the fourth largest contract research organisation (CRO).

Molecular Profiles to Formulate Psoriasis Drug in Multi-Firm Project

24-Sep-2013 - Molecular Profiles has been chosen to develop topical and solid dose formulations of a preclinical psoriasis treatment as part of a multicompany conglomerate led by Telormedix.

Columbia Labs add Molecular Profiles CEO to board and plans contracting biz

17-Sep-2013 - Recent entrant into the formulation services sector Columbia Laboratories has added Molecular Profiles execs to its board.

Up to 30% of CMO to Exit Biz in Next 10 Years, Report Says

10-Sep-2013 - The CMO market remains highly fragmented with thirty percent of active players likely to exit the business in the next ten years, according to a Frost & Sullivan report.

Patheon's Q3 Sales and CMO Business Bolstered by Banner Integration

09-Sep-2013 - Patheon has reported increased revenue growth for Q3 2013 following the full completion of Banner and says more industry consolidation is likely.


CrownBio Buys Precos for Cancer tech and European Reach

30-Jul-2013 - US CRO Crown BioSciences has acquired Precos citing the UK contractor’s preclinical oncology services and presence in the European market as the key drivers.

CRA Buys Psychiatric Trial Firm CCD

25-Jul-2013 - Clinical Research Advantage (CRA) has acquired the late phase business of Comprehensive Clinical Development (CCD) adding psychiatric clinical trials to its services.

PRA says Clinstar Takeover Offers Quicker and Cheaper Patient Enrollment

05-Mar-2013 - US CRO PRA international has expanded its presence in Eastern Europe with the acquisition of privately-owned trial services firm ClinStar.

Quintiles and TPG tight-lipped on latest IPO rumours

29-Jan-2013 - Quintiles and investor TPG Capital declined to comment on rumours the CRO is sizing up banks and preparing for an IPO.

Medpace boost EU device offering through Meditech takeover

20-Nov-2012 - Medpace has acquired Meditech Strategic Consulting in a bid to expand its European clinical trial services.

CRO round-up: collaboration, expansions and small providers teaming-up to take on the big players

14-Nov-2012 - A new personalised medicine-focused partnership for AstraZeneca, expansion in three continents for World Wide clinical and six small CROs team-up to create one super-team. presents a round-up of the...


PCT Europe 2012: Managing risk, emerging markets and industry criticism

08-Nov-2012 - is in Hamburg,Germany this week to meet the CROs, sponsors and academics gathered at PCT Europe to discuss the future of partnerships in clinical trials.

Key Industry Events


Access all events listing

Our events, Events from partners...